durapatite has been researched along with Osteomyelitis in 69 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (4.35) | 18.7374 |
| 1990's | 13 (18.84) | 18.2507 |
| 2000's | 7 (10.14) | 29.6817 |
| 2010's | 34 (49.28) | 24.3611 |
| 2020's | 12 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Du, M; Feng, G; He, M; Hu, B; Huang, L; Huang, Y; Li, Y; Li, Z; Liu, L; Song, Y; Sun, D; Wang, J; Zhang, L; Zhu, C | 1 |
| Arumugam, S; Boniface Fernandez, F; P R, HV; Parayanthala Valappil, M; Sivadasan, SB; Unnikrishnan, V; Venugopal, A | 1 |
| Lv, XF; Sun, XH; Zhao, Z; Zhou, DM | 1 |
| Cheng, X; Peng, C; Ren, G; Wang, Q; Wang, Y; Yuan, B; Zhang, Y; Zhou, S | 1 |
| Chen, X; Gong, H; Guo, Z; Hu, D; Li, J; Mu, Y; Sun, T; Weng, J; Xin, Q | 1 |
| Chen, C; Cherian, P; Ebetino, FH; Hu, E; Junka, AF; McKenna, CE; Neighbors, J; Pawlak, J; Roshandel, S; Russell, RGG; Sedghizadeh, PP; Sodagar, E; Sun, S; Tjokro, N | 1 |
| Baldini, M; Laiuppa, JA; Messina, PV; Placente, D; Ruso, JM; Santillán, GE; Sieben, JM | 1 |
| Cheng, L; Hu, Y; Lan, F; Li, M; Ma, Y; Oates, TW; Peng, X; Ren, B; Weir, MD; Wu, Y; Xu, HHK; Zhou, W; Zhou, X | 1 |
| Egawa, S; Hirai, K; Matsumoto, R; Okawa, A; Sotome, S; Sugo, K; Yoshii, T; Yuasa, M | 1 |
| Biswas, R; Krishnan, AG; Menon, D; Nair, MB | 1 |
| Konopacka, A; Prokopowicz, M; Sądej, R; Skwira, A; Szewczyk, A; Walker, G | 1 |
| Chandran, KR; Iraivan, G; Mohan, P; Nagaiah, HP; Rajendran, M; Selvaraj, RCA | 1 |
| Alghazali, K; Anderson, DE; Beenken, KE; Biris, AS; Bourdo, SE; Campbell, MJ; Griffin, C; Hecht, S; Jackson, B; King, W; Meeker, DG; Ramirez, AM; Rifkin, R; Smeltzer, MS; Walker, CM | 1 |
| Ito, A; Makiishi, J; Matsuno, T; Satoh, T; Sogo, Y | 1 |
| David, N; Nallaiyan, R | 1 |
| Balal, M; Drampalos, E; Kosmidis, C; Mohammad, HR; Pillai, A; Wong, J | 1 |
| Andrés, NC; Baldini, M; Famiglietti, Á; Messina, PV; Rodríguez, CH; Sieben, JM | 1 |
| Karr, JC | 1 |
| Drampalos, E; Jahangir, N; Morrissey, N; Niazi, NS; Pillai, A; Wee, A | 1 |
| Amarnath Praphakar, R; Rajan, M; Sam Ebenezer, R; Shakila, H; Sumathra, M; Vignesh, S | 1 |
| Desai, TA; Uskoković, V | 2 |
| Biswas, R; Jayaram, L; Krishnan, AG; Nair, M | 1 |
| Heiss, C; Hess, U; Hill, S; Rezwan, K; Streckbein, P; Treccani, L | 1 |
| Cao, ZD; Jiang, DM; Li, YJ; Wang, X; Wang, ZL; Wu, J; Yan, L; Yi, YF | 1 |
| Fu, Q; Huang, WH; Jia, WT; Rahaman, MN; Zhang, CQ | 1 |
| Albayati, ZA; Breen, PJ; Crooks, PA; Karau, MJ; Merten, KE; Morris, AJ; Patel, R; Pierce, WM; Schmidt-Malan, SM; Smeltzer, MS; Steckelberg, JM; Sunkara, M; Taylor, KG | 1 |
| Cao, Z; Jiang, D; Wu, J; Yan, L | 1 |
| Fan, XY; He, XQ; Jin, T; Li, Y; Wang, H; Wang, Y; Xu, YQ | 1 |
| Ben-Nissan, B; Cazalbou, S; Choi, AH; Macha, I | 1 |
| Ghosh, S; Pernal, S; Uskoković, V; Wu, V | 1 |
| Aizawa, M; Funao, H; Hoshikawa, T; Ishii, K; Koyasu, S; Matsumoto, M; Nagai, S; Nakamura, M; Okada, Y; Sasaki, A; Toyama, Y; Tsuji, T | 1 |
| Atkins, BL; Diefenbeck, M; Ferguson, JY; Lau, AC; McNally, MA; Ramsden, AJ; Scarborough, M | 1 |
| Dong, J; He, TC; Jiang, D; Li, J; Liao, J; Lu, M; Qiu, H; Quan, Z; Wu, J; Zhou, X | 1 |
| Bartoszewicz, M; Bil-Lula, I; Junka, A; Karuga-Kuzniewska, E; Mahabady, S; Sedghizadeh, PP; Smutnicka, D; Szymczyk, P; Ziółkowski, G | 1 |
| Chen, C; Gu, H; He, X; Huang, W; Jiang, J; Li, J; Liu, W; Wang, Q; Zhang, D; Zhou, N | 1 |
| Kobayashi, S; Miyamoto, K; Nomura, M; Sakura, N; Takahashi, T; Yokogawa, K | 1 |
| Li, X; Li, Y; Liu, H; Morsi, YS; Shi, P; Zhang, L; Zou, Q; Zuo, Y | 1 |
| Basu, D; Bhattacharya, RN; Dandapat, N; Datta, BK; Kundu, B; Mandal, TK; Mukherjee, P; Nandi, SK; Roy, S; Soundrapandian, C | 1 |
| Ishimaru, D; Ito, Y; Ogawa, H; Shimizu, K | 1 |
| Laha, B; Nayak, AK; Sen, KK | 1 |
| Dong, J; Fang, TL; Jiang, JL; Li, XL; Li, YF; Wang, YC; Zhou, J | 1 |
| Aalbæk, B; Dahl-Petersen, K; Frees, D; Heegaard, PM; Iburg, TM; Jensen, HE; Johansen, LK; Koch, J; Leifsson, PS; Nielsen, OL | 1 |
| Fan, X; Huang, J; Ma, T; Tang, H; Xu, Y | 1 |
| Kaewsrichan, J; Thanyaphoo, S | 1 |
| Dayi, E; Gündoğdu, B; Gürsan, N; Kaya, M; Kireççi, E; Şimşek-Kaya, G | 1 |
| Hasnain, MS; Malakar, J; Nayak, AK | 1 |
| Calhoun, JH; Mader, JT; Shirtliff, ME | 1 |
| Akkan, G; Heybeli, N; Oktar, FN; Ozsoy, S; Ozyazgan, S | 1 |
| Brandt, B; Gosheger, G; Joist, A; Joosten, U; Liljenqvist, U; von Eiff, C | 1 |
| Kwan, MK; Merican, AM; Ng, WM | 1 |
| Bostrom, M; Gardner, M; Griffith, M; Wanich, T; Zelken, J | 1 |
| Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I | 1 |
| Itokazu, M; Kumazawa, S; Matsunaga, T; Yang, W | 1 |
| Bender, E; Dumbach, J; Rodemer, H; Spitzer, WJ | 1 |
| Jundt, G; Ochsner, PE; Pfister, A | 1 |
| Araki, N; Inoue, K; Korkusuz, F; Ono, K; Shinto, Y; Uchida, A | 1 |
| Asai, T; Nagaya, I; Shinjo, K; Tukamoto, M | 1 |
| Brause, BD; Cornell, CN; Lane, JM; Tyndall, D; Waller, S | 1 |
| Iida, H; Kawanabe, K; Matsusue, Y; Nakamura, T; Okada, Y | 1 |
| Araki, N; Kato, K; Shinto, Y; Uchida, A; Yamakawa, T; Yamashita, Y | 1 |
| Aoki, T; Itoh, Y; Itokazu, M; Nishimoto, Y; Nonomura, H | 1 |
| Baumgaertner, MR; Gutow, AP; Solberg, BD | 1 |
| Erokina, NL; Lepilin, AV; Shirokov, VIu; Volozhin, AI | 1 |
| Itokazu, M; Kumazawa, S; Matsunaga, T; Oka, M | 1 |
| Araki, N; Korkusuz, F; Ono, K; Shinto, Y; Uchida, A | 1 |
| Gilmore, WC; Reznick, JB | 1 |
| Eitenmüller, J; Gellissen, G; Peters, G; Reichmann, W; Schmidt, KH; Weltin, R | 1 |
| Block, MS; Kent, JN; Zide, MF | 1 |
2 review(s) available for durapatite and Osteomyelitis
| Article | Year |
|---|---|
Calcium phosphate nanocoatings and nanocomposites, part 2: thin films for slow drug delivery and osteomyelitis.
Topics: Bone Regeneration; Calcium Phosphates; Coated Materials, Biocompatible; Drug Delivery Systems; Durapatite; Humans; Nanocomposites; Osteomyelitis | 2016 |
Surgical treatment of an infant with Bacille Calmette-Guérin osteomyelitis extending across the growth plate.
Topics: Anti-Bacterial Agents; BCG Vaccine; Bone Substitutes; Curettage; Durapatite; Growth Plate; Humans; Infant; Isoniazid; Knee Joint; Male; Meta-Analysis as Topic; Osteomyelitis; Pyrazinamide; Recurrence; Reoperation; Rifampin; Tibia | 2011 |
67 other study(ies) available for durapatite and Osteomyelitis
| Article | Year |
|---|---|
3D-Printed Multifunctional Polyetheretherketone Bone Scaffold for Multimodal Treatment of Osteosarcoma and Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzophenones; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Cisplatin; Combined Modality Therapy; Durapatite; Graphite; Humans; Infrared Rays; Male; Mice, Inbred BALB C; Mice, Nude; Nanocomposites; Osteomyelitis; Osteosarcoma; Photothermal Therapy; Polymers; Printing, Three-Dimensional; Quaternary Ammonium Compounds; Rats, Sprague-Dawley; Tissue Scaffolds | 2021 |
Cellular and sub-chronic toxicity of hydroxyapatite porous beads loaded with antibiotic in rabbits, indented for chronic osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Durapatite; Female; Osteomyelitis; Porosity; Rabbits | 2022 |
Nano Sized Hydroxyapatite-Polylactic Acid-Vancomycin in Alleviation of Chronic Osteomyelitis.
Topics: Animals; Durapatite; Mice; Osteomyelitis; Polyesters; Tissue Scaffolds; Vancomycin | 2022 |
Thermosensitive vancomycin@PLGA-PEG-PLGA/HA hydrogel as an all-in-one treatment for osteomyelitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Delayed-Action Preparations; Drug Carriers; Durapatite; Humans; Hydrogels; Micelles; Osteomyelitis; Polyethylene Glycols; Polymers; Spectroscopy, Fourier Transform Infrared; Vancomycin | 2022 |
Hexapeptide decorated β-cyclodextrin delivery system for targeted therapy of bone infection.
Topics: Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Drug Delivery Systems; Durapatite; Mice; Mice, Nude; Osteomyelitis; Pharmaceutical Preparations; Polyethylene Glycols; Rats | 2023 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etidronic Acid; Humans; Microbial Sensitivity Tests; Moxifloxacin; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Self-fluorescent antibiotic MoO
Topics: Anti-Bacterial Agents; Bacterial Infections; Durapatite; Fluorescent Dyes; Nanoparticles; Osteomyelitis; Theranostic Nanomedicine | 2019 |
Two-staged time-dependent materials for the prevention of implant-related infections.
Topics: Animals; Anti-Bacterial Agents; Bone Marrow Cells; Cells, Cultured; Disease Models, Animal; Durapatite; Female; Humans; Implants, Experimental; Mesenchymal Stem Cells; Methacrylates; Osteomyelitis; Prosthesis-Related Infections; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Titanium | 2020 |
Efficacy of Antibiotic-Loaded Hydroxyapatite/Collagen Composites Is Dependent on Adsorbability for Treating Staphylococcus aureus Osteomyelitis in Rats.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Bone Regeneration; Cefazolin; Collagen; Drug Evaluation, Preclinical; Drug Implants; Durapatite; Male; Osteomyelitis; Rats, Wistar; Staphylococcal Infections; Vancomycin | 2020 |
Biodegradable nanocomposite fibrous scaffold mediated local delivery of vancomycin for the treatment of MRSA infected experimental osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Drug Delivery Systems; Durapatite; Gelatin; Male; Methicillin-Resistant Staphylococcus aureus; Nanocomposites; Osteomyelitis; Polyesters; Rats, Wistar; Silicon Dioxide; Staphylococcal Infections; Vancomycin | 2020 |
Mesoporous silica pellets as bifunctional bone drug delivery system for cefazolin.
Topics: Anti-Bacterial Agents; Cefazolin; Cell Line; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Implants; Drug Liberation; Durapatite; Hardness; Humans; Kinetics; Osteoblasts; Osteomyelitis; Porosity; Silicon Dioxide; Staphylococcus aureus; Surface Properties | 2020 |
Antibiotic Loaded Nano Rod Bone Cement for the Treatment of Osteomyelitis.
Topics: Anti-Bacterial Agents; Bone Cements; Durapatite; Humans; Osteomyelitis; Polymethyl Methacrylate | 2021 |
Evaluation of a bone filler scaffold for local antibiotic delivery to prevent Staphylococcus aureus infection in a contaminated bone defect.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Regeneration; Disease Models, Animal; Drug Delivery Systems; Durapatite; Gentamicins; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin; X-Ray Microtomography | 2021 |
In vitro/in vivo evaluation of the efficacy of gatifloxacine-loaded PLGA and hydroxyapatite composite for treating osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Biocompatible Materials; Bone Regeneration; Debridement; Drug Carriers; Durapatite; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Lactic Acid; Mandible; Materials Testing; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Rabbits; Streptococcus milleri Group | 2017 |
Biologically anchored chitosan/gelatin-SrHAP scaffold fabricated on Titanium against chronic osteomyelitis infection.
Topics: Anti-Bacterial Agents; Chronic Disease; Drug Delivery Systems; Drugs, Chinese Herbal; Durapatite; Gelatin; Humans; Mesenchymal Stem Cells; Osteomyelitis; Strontium; Titanium; Vancomycin | 2018 |
Single stage treatment of diabetic calcaneal osteomyelitis with an absorbable gentamicin-loaded calcium sulphate/hydroxyapatite biocomposite: The Silo technique.
Topics: Absorbable Implants; Aged; Aged, 80 and over; Calcaneus; Calcium Sulfate; Chronic Disease; Combined Modality Therapy; Databases, Factual; Debridement; Diabetic Foot; Drug Delivery Systems; Durapatite; Female; Gentamicins; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Radiography; Retrospective Studies; Surgical Flaps; Treatment Outcome; Wound Healing | 2018 |
Electroactive Mg
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Coated Materials, Biocompatible; Durapatite; Escherichia coli; Humans; Magnesium; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcus aureus | 2018 |
Lower-Extremity Osteomyelitis Treatment Using Calcium Sulfate/Hydroxyapatite Bone Void Filler with Antibiotics
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Substitutes; Calcium Sulfate; Child; Durapatite; Female; Humans; Lower Extremity; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Adjuvant antibiotic loaded bio composite in the management of diabetic foot osteomyelitis - A multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Calcium Sulfate; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Durapatite; Female; Humans; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Wound Healing; Young Adult | 2019 |
Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.
Topics: Animals; Antitubercular Agents; Carrageenan; Cell Line; Drug Delivery Systems; Drug Liberation; Durapatite; Erythrocytes; Hemolysis; Humans; Isoniazid; Klebsiella pneumoniae; Macrophages; Maleic Anhydrides; Mice; Nanocomposites; Osteoblasts; Osteomyelitis; Regeneration; Rifampin; Staphylococcus aureus; Tuberculosis | 2019 |
In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis.
Topics: 3T3 Cells; Algorithms; Animals; Anti-Bacterial Agents; Cell Line; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Durapatite; Light; Mice; Microbial Sensitivity Tests; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Osteomyelitis; Particle Size; Real-Time Polymerase Chain Reaction; Scattering, Radiation; Spectrophotometry, Ultraviolet; Staphylococcus aureus | 2014 |
Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacterial Adhesion; Cells, Cultured; Ciprofloxacin; Drug Delivery Systems; Drug Liberation; Durapatite; Gelatin; Humans; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Osteomyelitis; Spectroscopy, Fourier Transform Infrared; Tissue Scaffolds; X-Ray Diffraction | 2015 |
A mild one-pot process for synthesising hydroxyapatite/biomolecule bone scaffolds for sustained and controlled antibiotic release.
Topics: Agar; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Bone Substitutes; Cattle; Diffusion; Drug Delivery Systems; Durapatite; Fibrinogen; Gentamicins; Materials Testing; Osteomyelitis; Porosity; Pressure; Serum Albumin; Stress, Mechanical; Tissue Scaffolds; Vancomycin | 2015 |
Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Chronic Disease; Delayed-Action Preparations; Drug Carriers; Durapatite; Lactic Acid; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Comparison of Borate Bioactive Glass and Calcium Sulfate as Implants for the Local Delivery of Teicoplanin in the Treatment of Methicillin-Resistant Staphylococcus aureus-Induced Osteomyelitis in a Rabbit Model.
Topics: Animals; Anti-Bacterial Agents; Boron Compounds; Calcium Sulfate; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Female; Glass; Injections, Intralesional; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rabbits; Staphylococcal Infections; Teicoplanin; Tibia; Treatment Outcome | 2015 |
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Debridement; Disease Models, Animal; Drug Carriers; Durapatite; Humans; Osteomyelitis; Polyethylene Glycols; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
In vitro and in vivo osteogenic activity of the novel vancomycin-loaded bone-like hydroxyapatite/poly(amino acid) scaffold.
Topics: Animals; Anti-Bacterial Agents; Bone Substitutes; Cell Line; Drug Carriers; Durapatite; Humans; Osteoblasts; Osteogenesis; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tissue Scaffolds; Vancomycin | 2016 |
Wnt11 plays an important role in the osteogenesis of human mesenchymal stem cells in a PHA/FN/ALG composite scaffold: possible treatment for infected bone defect.
Topics: Adult; Alginates; Animals; Bone Regeneration; Cell Adhesion; Cell Differentiation; Cell Proliferation; Cells, Cultured; Culture Media; Durapatite; Female; Fibronectins; Glucuronic Acid; Hexuronic Acids; Humans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Middle Aged; Osteogenesis; Osteomyelitis; Rabbits; Radiography; Regenerative Medicine; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tissue Engineering; Tissue Scaffolds; Transfection; Wnt Proteins | 2016 |
Self-Setting Calcium Phosphate Cements with Tunable Antibiotic Release Rates for Advanced Antimicrobial Applications.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bone Cements; Cell Line; Delayed-Action Preparations; Durapatite; Mice; Osteomyelitis | 2016 |
A novel hydroxyapatite film coated with ionic silver via inositol hexaphosphate chelation prevents implant-associated infection.
Topics: Animals; C-Reactive Protein; Cell Line; Cell Survival; Chelating Agents; Coated Materials, Biocompatible; Disease Models, Animal; Durapatite; Femur; Interleukin-6; Ions; Luminescent Measurements; Mice; Osteomyelitis; Phytic Acid; Prostheses and Implants; Silver; Spectrophotometry, Atomic; Staphylococcus aureus | 2016 |
Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases.
Topics: Biocompatible Materials; Bone Regeneration; Bone Substitutes; Calcium Sulfate; Chronic Disease; Cohort Studies; Debridement; Drug Implants; Durapatite; Female; Follow-Up Studies; Gentamicins; Humans; Male; Osteomyelitis; Prospective Studies; Radiography; Risk Assessment; Treatment Outcome; Wound Healing | 2016 |
An effective treatment of experimental osteomyelitis using the antimicrobial titanium/silver-containing nHP66 (nano-hydroxyapatite/polyamide-66) nanoscaffold biomaterials.
Topics: Animals; Anti-Infective Agents; Biocompatible Materials; Biomarkers; Cell Adhesion; Cell Line; Cell Proliferation; Durapatite; Escherichia coli; Gene Expression Regulation; Mice; Nanoparticles; Nylons; Osteoblasts; Osteogenesis; Osteomyelitis; Rabbits; Silver; Staphylococcus aureus; Titanium | 2016 |
Bad to the Bone: On In Vitro and Ex Vivo Microbial Biofilm Ability to Directly Destroy Colonized Bone Surfaces without Participation of Host Immunity or Osteoclastogenesis.
Topics: Animals; Biofilms; Candida albicans; Durapatite; Jaw; Male; Osteoblasts; Osteomyelitis; Polystyrenes; Pseudomonas aeruginosa; Rats; Rats, Wistar; Staphylococcus aureus | 2017 |
Levofloxacin loaded mesoporous silica microspheres/nano-hydroxyapatite/polyurethane composite scaffold for the treatment of chronic osteomyelitis with bone defects.
Topics: Absorbable Implants; Animals; Bone and Bones; Bone Regeneration; Chronic Disease; Disease Models, Animal; Durapatite; Immunohistochemistry; Levofloxacin; Microspheres; Nanoparticles; Osteomyelitis; Polyurethanes; Rabbits; Radiography; Silicon Dioxide; Tissue Scaffolds; X-Ray Microtomography | 2017 |
Bone-targeting of quinolones conjugated with an acidic oligopeptide.
Topics: Animals; Anti-Bacterial Agents; Drug Delivery Systems; Durapatite; Female; Mice; Oligopeptides; Osteomyelitis; Quinolones; Tissue Distribution | 2008 |
Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy.
Topics: Animals; Cell Death; Cell Survival; Cellulose; Chitosan; Chronic Disease; Durapatite; Fibroblasts; Gentamicins; Humans; Implants, Experimental; Microspheres; Nanostructures; Osteoblasts; Osteomyelitis; Rabbits; Radiography; Rats; Rats, Wistar; Staphylococcus aureus; Tibia | 2010 |
Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Durapatite; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Osteomyelitis; Porosity; Powders; Rabbits; Staphylococcus aureus; Sulbactam; X-Ray Diffraction | 2010 |
Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".
Topics: Anti-Bacterial Agents; Biocompatible Materials; Chemical Precipitation; Ciprofloxacin; Delayed-Action Preparations; Drug Implants; Durapatite; Excipients; Galactans; Humans; Mannans; Models, Theoretical; Osteomyelitis; Phosphoric Acids; Plant Gums; Time Factors | 2011 |
Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Carriers; Drug Implants; Durapatite; Methicillin-Resistant Staphylococcus aureus; Nanostructures; Osteomyelitis; Rabbits; Radiography; Staphylococcal Infections; Tibia; Vancomycin | 2012 |
Local osteogenic expression of cyclooxygenase-2 and systemic response in porcine models of osteomyelitis.
Topics: Alkaline Phosphatase; Animals; Cyclooxygenase 2; Durapatite; Haptoglobins; Immunohistochemistry; Models, Animal; Osteoblasts; Osteomyelitis; Staphylococcal Infections; Swine | 2012 |
[Vancomycin cationic liposome combined with nano-hydroxyapatite/chitosan/konjac glucomannan scaffold for treatment of infected bone defects in rabbits].
Topics: Animals; Bone Diseases; Bone Regeneration; Chitosan; Chronic Disease; Durapatite; Liposomes; Mannans; Nanostructures; Osteomyelitis; Rabbits; Staphylococcal Infections; Tissue Scaffolds; Vancomycin | 2012 |
Synthesis and evaluation of novel glass ceramics as drug delivery systems in osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Substitutes; Cell Line; Cell Survival; Ceramics; Drug Delivery Systems; Durapatite; Humans; Osteomyelitis; Rats; Silicon Dioxide; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2012 |
Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biocompatible Materials; Chronic Disease; Colony Count, Microbial; Debridement; Drug Carriers; Durapatite; Male; Methicillin-Resistant Staphylococcus aureus; Minocycline; Osteomyelitis; Random Allocation; Rats; Rats, Wistar; Tibia; Tigecycline | 2012 |
Development and optimization of hydroxyapatite-ofloxacin implants for possible bone delivery in osteomyelitis treatment.
Topics: Anti-Bacterial Agents; Bone and Bones; Drug Implants; Durapatite; Humans; Ofloxacin; Osteomyelitis | 2013 |
Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Delayed-Action Preparations; Durapatite; Humans; Nanoparticles; Osteomyelitis | 2013 |
Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Drug Delivery Systems; Durapatite; Female; Osteomyelitis; Polymethyl Methacrylate; Prostheses and Implants; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia; Vancomycin | 2002 |
Low-cost antibiotic loaded systems for developing countries.
Topics: Alginates; Animals; Biocompatible Materials; Calcium Sulfate; Cefazolin; Ceramics; Chromatography, High Pressure Liquid; Chronic Disease; Developing Countries; Drug Delivery Systems; Drug Implants; Durapatite; Glucuronic Acid; Hexuronic Acids; Microbial Sensitivity Tests; Osteomyelitis; Polymethyl Methacrylate; Rabbits; Staphylococcus aureus | 2003 |
Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Topics: Animals; Biological Availability; Body Weight; Bone Cements; C-Reactive Protein; Chronic Disease; Disease Models, Animal; Drug Carriers; Durapatite; Leukocyte Count; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Melioidotic osteomyelitis treated with antibiotic-calcium hydroxyapatite composite: case report with four-year follow-up.
Topics: Adult; Anti-Bacterial Agents; Burkholderia pseudomallei; Ceftazidime; Drug Administration Routes; Durapatite; Femur; Follow-Up Studies; Humans; Male; Melioidosis; Osteomyelitis | 2006 |
PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Colony Count, Microbial; Disease Models, Animal; Drug Carriers; Durapatite; Female; Microbial Viability; Osteomyelitis; Polymethacrylic Acids; Radiography; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Tibia; Treatment Outcome; Vancomycin | 2007 |
Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Blood Platelets; Body Weight; Calcium Phosphates; Ciprofloxacin; Disease Models, Animal; Durapatite; Femur; Gamma Rays; Humans; Implants, Experimental; Leukocytes; Male; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2008 |
A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Drug Delivery Systems; Durapatite; Humans; Osteomyelitis | 1995 |
[Limits of osseous reconstruction of the mandible with autologous spongiosa, hydroxyapatite granules and titanium mesh, especially after radiotherapy].
Topics: Adult; Aged; Bone Transplantation; Durapatite; Female; Humans; Male; Mandible; Mandibular Diseases; Mandibular Fractures; Mandibular Neoplasms; Middle Aged; Osteomyelitis; Osteoradionecrosis; Postoperative Complications; Prostheses and Implants; Pseudarthrosis; Radiography; Reoperation; Surgical Mesh; Titanium; Wounds, Gunshot | 1994 |
[Bone biopsies of cortical bone segments (technique, evaluation)].
Topics: Biopsy; Bone and Bones; Bone Cysts; Chronic Disease; Durapatite; Equipment Design; Humans; Osteocytes; Osteomyelitis; Pseudarthrosis; Quality Control | 1993 |
Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites.
Topics: Animals; Ceramics; Drug Carriers; Durapatite; Female; Gentamicins; Hydroxyapatites; Injections, Intraperitoneal; Microscopy, Electron, Scanning; Osteomyelitis; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus | 1993 |
[One stage operation for dead space of pyogenic and tuberculous osteomyelitis].
Topics: Adult; Biocompatible Materials; Durapatite; Female; Fibrin Tissue Adhesive; Follow-Up Studies; Humans; Male; Middle Aged; Orthopedics; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Suppuration; Tuberculosis, Osteoarticular | 1993 |
Treatment of experimental osteomyelitis with antibiotic-impregnated bone graft substitute.
Topics: Animals; Bone Transplantation; Chronic Disease; Colony Count, Microbial; Combined Modality Therapy; Debridement; Disease Models, Animal; Drug Carriers; Durapatite; Gentamicins; Microbial Sensitivity Tests; Microspheres; Osteomyelitis; Rabbits; Radiography; Random Allocation; Staphylococcus aureus; Time Factors | 1993 |
Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic.
Topics: Adult; Animals; Anti-Bacterial Agents; Apatites; Arthroplasty, Replacement, Hip; Calcium Compounds; Cefmetazole; Cephamycins; Ceramics; Drug Delivery Systems; Drug Implants; Drug Therapy, Combination; Durapatite; Female; Femur; Gentamicins; Glass; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Pilot Projects; Porosity; Prosthesis-Related Infections; Rabbits; Silicates; Tibia; Time Factors | 1998 |
Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Biocompatible Materials; Ceramics; Chronic Disease; Debridement; Drug Implants; Durapatite; Female; Follow-Up Studies; Humans; Male; Middle Aged; Osseointegration; Osteomyelitis; Radiography; Treatment Outcome | 1998 |
Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biocompatible Materials; Combined Modality Therapy; Curettage; Drug Implants; Durapatite; Female; Follow-Up Studies; Gentamicins; Humans; Infusions, Intravenous; Joint Prosthesis; Male; Osteomyelitis; Porosity; Prosthesis-Related Infections; Radiography; Treatment Outcome | 1998 |
Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model.
Topics: Absorbable Implants; Animals; Biocompatible Materials; Biodegradation, Environmental; Bone Cements; Chronic Disease; Disease Models, Animal; Drug Implants; Durapatite; Female; Gentamicins; Osteomyelitis; Rats; Rats, Sprague-Dawley; Reference Values; Staphylococcal Infections; Treatment Outcome | 1999 |
[The optimization of the reparative processes in a mandibular bone wound in patients with chronic alcoholism].
Topics: Adult; Alcoholism; Bone Regeneration; Bone Substitutes; Chronic Disease; Drug Therapy, Combination; Durapatite; Humans; Male; Mandible; Mandibular Fractures; Middle Aged; Osteomyelitis; Wound Healing | 1998 |
Treatment of osteomyelitis by antibiotic impregnated porous hydroxyapatite block.
Topics: Adolescent; Alcaligenes; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Delivery Systems; Durapatite; Female; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus epidermidis; Tuberculosis | 1994 |
Calcium hydroxyapatite ceramic used as a delivery system for antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biological Assay; Cefoperazone; Cephalosporins; Ceramics; Drug Carriers; Durapatite; Gentamicins; Hydroxyapatites; In Vitro Techniques; Microbiological Techniques; Osteomyelitis; Rats; Rats, Inbred Strains | 1992 |
Host response to infection of a subperiosteal hydroxylapatite implant.
Topics: Alveolar Ridge Augmentation; Animals; Bacteroides Infections; Biocompatible Materials; Connective Tissue; Durapatite; Hydroxyapatites; Mandible; Osteitis; Osteomyelitis; Pilot Projects; Prevotella melaninogenica; Prostheses and Implants; Rabbits; Wound Healing | 1989 |
Experimental and preliminary clinical experience with absorbable calcium phosphate granules containing an antibiotic or antiseptic for the local treatment of osteomyelitis.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bone Regeneration; Combined Modality Therapy; Dogs; Drug Implants; Durapatite; Female; Floxacillin; Fosfomycin; Humans; Hydroxyapatites; Male; Middle Aged; Osteomyelitis; Povidone-Iodine | 1985 |
Excision of sclerosing osteomyelitis and reconstruction with particulate hydroxylapatite.
Topics: Aged; Alveoloplasty; Bone Transplantation; Durapatite; Female; Humans; Hydroxyapatites; Mandibular Diseases; Middle Aged; Osteomyelitis; Prostheses and Implants; Sclerosis | 1986 |